Search

‘High-risk drug use and new psychoactive substances’, a new report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), takes a look at the emergence of more problematic forms of new psychoactive substance use among a...

For the first time in a prison setting, a randomised trial has rigorously compared intensive residential therapeutic community treatment to outpatient counselling. Confounding expectations, the US prison for problem drug users which hosted...

This misuse of prescription opioids is a major public health challenge. Buprenorphine-naloxone (bup-nx) is typically used to treat opioid use disorders. However, the drug’s clinical trial primarily involved heroin users. It was therefore...

The over-prescription of opioids is a significant public health issue in the United States. For example, opioids are often prescribed for minor injuries unnecessarily. This, in turn, increases the risk of addiction.

New research presented...

Thirteen years have passed since the US Food and Drug Administration (FDA) last approved a new medication to help the nation’s millions of people with alcohol use disorder (AUD) stop or moderate their drinking.

Only 3 such formulations...

Background

Screening and brief interventions for alcohol are an effective public health measure to tackle alcohol-related harm, however relatively few countries across the European Union (EU) have implemented them widely. This may be due...

New research published in the Journal of Neural Transmission highlights a number of potential adverse side-effects from using the stimulant drug Ritalin without a prescription. Ritalin (Methylphenidate) is medically used to treat Attention...

The final row of the Alcohol Treatment Matrix enters the domain of treatment organised not primarily for the patient, but to safeguard the wider community, encountering what seems a core contradiction depicted on the cover of WHO guidance...

A free online training course from the Centers for Disease Control and Prevention (CDC) is now available.

The course addresses the CDC recommendations with respect to the prescription of opioids for chronic pain as well as their treatment...

This report brings together information on people receiving specialist interventions for drug problems and for problem drinking in England, other than patients receiving this treatment in prison.

Analysed textually and pictorially through...

A recently published White Paper by the Addiction Technology Transfer Centre Newtork (ATTC) starts with the premise that the substance use disorder (SUD) prevention, treatment and recovery workforce is currently undergoing an evolution as a...

A new study published in the Journal of Addiction Medicine suggests that a tele-psychiatric approach which uses video-link technology in combination with medicinal treatment in the form of buprenorphine could be as effective as the usual...

The Canadian Centre on Substance Abuse (CCSA) has released a new report detailing possible effects of psychoactive prescription drugs while driving. The study was carried out with the effort to inform policy decisions aimed at reducing the...

The European Facility Survey Questionnaire (EFSQ) can be used for data collection in any country by those looking to investigate facilities that provide interventions for drug users.

Its aim is to collect information on facilities in...

New Research published in the Journal of Clinical Psychiatry has found that people with intermittent explosive disorder (IED) – a condition with a significant genetic component characterised by regular outbursts of aggression, whether...

The Talking Route to Recovery

Time to consolidate the lessons of last five instalments of the online course on alcohol treatment research. Every treatment involves direct or indirect human interaction, but this row is about therapies in...